Cleared Traditional

LEVO MOBIL LCM (K963817) - FDA 510(k) Clearance

Class II Physical Medicine device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K963817 · Levo USA · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1997
Decision
456d
Days
Class 2
Risk

K963817 is an FDA 510(k) clearance for the LEVO MOBIL LCM. Classified as Wheelchair, Standup (product code IPL), Class II - Special Controls.

Submitted by Levo USA (Dottikon, CH). The FDA issued a Cleared decision on December 23, 1997 after a review of 456 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.3900 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Physical Medicine submissions.

View all Levo USA devices

Submission Details

510(k) Number K963817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 1996
Decision Date December 23, 1997
Days to Decision 456 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
341d slower than avg
Panel avg: 115d · This submission: 456d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IPL Wheelchair, Standup
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.3900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPL Wheelchair, Standup

All 65
Devices cleared under the same product code (IPL) and FDA review panel - the closest regulatory comparables to K963817.
Walking rehabilitation training electric wheelchair (ZW518)
K243783 · Shenzhen Zuowei Technology Co., Ltd. · Mar 2025
Action Trackchair Hawk
K202728 · Action Manufacturing, Inc. · Feb 2022
ParaMotion
K203761 · Powerbasetec GmbH · Jan 2022
Tek RMD (TEK ROBOTIC MOBILIZATION DEVICE) TEKRMD02, TEKRMD03, TEKRMD04, TEKRMD04, TEKRMD05, TEKRMD06, TEKRMD07, TEKRMD08
K191334 · Matia Robotics (Us), Inc. · May 2020
Explorer Mini
K190682 · Permobil AB · Feb 2020
F5 Corpus VS
K191874 · Permobil AB · Oct 2019